CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • May 7th, 2009 • EPIX Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 7th, 2009 Company Industry JurisdictionCONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”) dated as of May 7, 2009, by and among EPIX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and U.S. Bank National Association, a national banking association organized under the laws of the United States, as Rights Agent (the “Rights Agent”), in favor of each person (a “Holder”) who from time to time holds one or more contingent value rights (the “CVRs”) to receive contingent payments, in the amounts and subject to the terms and conditions set forth herein.
CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • April 7th, 2009 • EPIX Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 7th, 2009 Company Industry JurisdictionCONTINGENT VALUE RIGHTS AGREEMENT (this “Agreement”) dated as of [ ], 2009, by and among EPIX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and U.S. Bank National Association, a national banking association organized under the laws of the United States, as Rights Agent (the “Rights Agent”), in favor of each person (a “Holder”) who from time to time holds one or more contingent value rights (the “CVRs”) to receive contingent payments, in the amounts and subject to the terms and conditions set forth herein.